IBDEI1Z5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,871,0)
 ;;=AFTERCARE POST SURGERY^3^85
 ;;^UTILITY(U,$J,358.4,872,0)
 ;;=COMMON VASCULAR DX^1^85
 ;;^UTILITY(U,$J,358.4,873,0)
 ;;=POST-OP COMPLICATIONS^9^85
 ;;^UTILITY(U,$J,358.4,874,0)
 ;;=METASTATIC CANCER SITES^8^85
 ;;^UTILITY(U,$J,358.4,875,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^5^85
 ;;^UTILITY(U,$J,358.4,876,0)
 ;;=HEMATOLOGY/ONCOLOGY^6^85
 ;;^UTILITY(U,$J,358.4,877,0)
 ;;=INFECTIOUS DISEASE^7^85
 ;;^UTILITY(U,$J,358.4,878,0)
 ;;=BIOPSY^1^86
 ;;^UTILITY(U,$J,358.4,879,0)
 ;;=CENTRAL VENOUS ACCESS PROCEDURES^2^86
 ;;^UTILITY(U,$J,358.4,880,0)
 ;;=PERIPHERAL ANGIOPLASTIES^3^86
 ;;^UTILITY(U,$J,358.4,881,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^4^86
 ;;^UTILITY(U,$J,358.4,882,0)
 ;;=VASCULAR INJECTION PROCEDURES^5^86
 ;;^UTILITY(U,$J,358.4,883,0)
 ;;=NEW PATIENT^2^87
 ;;^UTILITY(U,$J,358.4,884,0)
 ;;=ESTABLISHED PATIENT^1^87
 ;;^UTILITY(U,$J,358.4,885,0)
 ;;=CONSULTATIONS^3^87
 ;;^UTILITY(U,$J,358.4,886,0)
 ;;=MFH-NON CLINICIAN VISIT CODES^2^88
 ;;^UTILITY(U,$J,358.4,887,0)
 ;;=NURSING PROCEDURES^3^88
 ;;^UTILITY(U,$J,358.4,888,0)
 ;;=SPLINTS^4^88
 ;;^UTILITY(U,$J,358.4,889,0)
 ;;=MFH-CLINICIAN VISIT CODES^1^88
 ;;^UTILITY(U,$J,358.4,890,0)
 ;;=VACCINE ADMINISTRATION^5^88
 ;;^UTILITY(U,$J,358.4,891,0)
 ;;=VACCINES^6^88
 ;;^UTILITY(U,$J,358.4,892,0)
 ;;=CARDIOVASCULAR^3^89
 ;;^UTILITY(U,$J,358.4,893,0)
 ;;=ENDOCRINE/METABOLIC^7^89
 ;;^UTILITY(U,$J,358.4,894,0)
 ;;=PULMONARY^22^89
 ;;^UTILITY(U,$J,358.4,895,0)
 ;;=EENT^6^89
 ;;^UTILITY(U,$J,358.4,896,0)
 ;;=MUSCULOSKELETAL^17^89
 ;;^UTILITY(U,$J,358.4,897,0)
 ;;=NEURO^18^89
 ;;^UTILITY(U,$J,358.4,898,0)
 ;;=MENTAL HEALTH^16^89
 ;;^UTILITY(U,$J,358.4,899,0)
 ;;=GASTROENTEROLOGY^8^89
 ;;^UTILITY(U,$J,358.4,900,0)
 ;;=GU/RENAL^9^89
 ;;^UTILITY(U,$J,358.4,901,0)
 ;;=WOMEN'S HEALTH^25^89
 ;;^UTILITY(U,$J,358.4,902,0)
 ;;=HEMATOLOGY/ONCOLOGY^10^89
 ;;^UTILITY(U,$J,358.4,903,0)
 ;;=INFECTIOUS DISEASE^12^89
 ;;^UTILITY(U,$J,358.4,904,0)
 ;;=DERMATOLOGY^5^89
 ;;^UTILITY(U,$J,358.4,905,0)
 ;;=HISTORY OF ILLNESS^11^89
 ;;^UTILITY(U,$J,358.4,906,0)
 ;;=INJURY/TRAUMA^13^89
 ;;^UTILITY(U,$J,358.4,907,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^24^89
 ;;^UTILITY(U,$J,358.4,908,0)
 ;;=SEXUAL TRAUMA^23^89
 ;;^UTILITY(U,$J,358.4,909,0)
 ;;=PAIN^20^89
 ;;^UTILITY(U,$J,358.4,910,0)
 ;;=OTHER REASONS^19^89
 ;;^UTILITY(U,$J,358.4,911,0)
 ;;=COMMON DIAGNOSES^2^89
 ;;^UTILITY(U,$J,358.4,912,0)
 ;;=PREVENTIVE MEDICINE CODES^21^89
 ;;^UTILITY(U,$J,358.4,913,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^89
 ;;^UTILITY(U,$J,358.4,914,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^4^89
 ;;^UTILITY(U,$J,358.4,915,0)
 ;;=LEGAL BLINDNESS^14^89
 ;;^UTILITY(U,$J,358.4,916,0)
 ;;=NEW PATIENT^2^90
 ;;^UTILITY(U,$J,358.4,917,0)
 ;;=ESTABLISHED PATIENT^1^90
 ;;^UTILITY(U,$J,358.4,918,0)
 ;;=CONSULTATIONS^3^90
 ;;^UTILITY(U,$J,358.4,919,0)
 ;;=IMMUNIZATIONS^2^91
 ;;^UTILITY(U,$J,358.4,920,0)
 ;;=INJECTION^3^91
 ;;^UTILITY(U,$J,358.4,921,0)
 ;;=SKIN TEST^10^91
 ;;^UTILITY(U,$J,358.4,922,0)
 ;;=NURSING PROCEDURES^5^91
 ;;^UTILITY(U,$J,358.4,923,0)
 ;;=MINOR PROCEDURES^4^91
 ;;^UTILITY(U,$J,358.4,924,0)
 ;;=SPLINTS^10^91
 ;;^UTILITY(U,$J,358.4,925,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^9^91
 ;;^UTILITY(U,$J,358.4,926,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^8^91
 ;;^UTILITY(U,$J,358.4,927,0)
 ;;=PREVENTIVE MED-EST PT^6^91
 ;;^UTILITY(U,$J,358.4,928,0)
 ;;=PREVENTIVE MED-NEW PT^7^91
 ;;^UTILITY(U,$J,358.4,929,0)
 ;;=IMMUNIZATION ADMIN^1^91
 ;;^UTILITY(U,$J,358.4,930,0)
 ;;=CARDIOVASCULAR^3^92
 ;;^UTILITY(U,$J,358.4,931,0)
 ;;=ENDOCRINE/METABOLIC^7^92
 ;;^UTILITY(U,$J,358.4,932,0)
 ;;=PULMONARY^22^92
